Australia's most trusted
source of pharma news
Wednesday, 03 June 2026
Posted 3 June 2026 PM
Homegrown generics mogul Dennis Bastas has again shot up the rich list, hitting 26th place on the AFR Rich List 2026 after his assumed wealth almost doubled.
Bastas saw his estimated wealth leap from $2.93 billion in April 2025 to $5.74 billion in April 2026, an increase of 95.9 per cent. This is largely down to his sale in August last year of a 25 per cent stake in his company DBG Health to a US merchant bank for $1.6 billion.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.